Merz Aesthetics to launch new cellulite treatment
Merz Aesthetics will introduce a new cellulite treatment to the UK and Ireland this year.
The Cellfina System aims to treat stubborn cellulite on the buttocks and thighs. The device works by releasing the brous septae, that cause the dimpled appearance of cellulite, through a targeted subcision approach. A vacuum assisted tissue capture platform is placed over the dimples, which provides control of the depth at 6 or 10mm and an area of release, resulting in a smoother appearance.
“This represents a key milestone on the road to strengthening our status as a global leader in aesthetics. We are proud to be introducing this promising new system in the U.S., the world’s biggest market for aesthetic treatment,” stated Philip Burchard, the CEO of Merz Pharma. “With our proprietary technology, we can offer women with cellulite lasting treatment results. In light of the widespread public interest that our Cellfina System got during the test phase in the U.S., we feel confident that we can satisfy high demand and achieve major success in the market. We plan to roll out Cellfina in Europe by year-end, and then in Asia and Latin America in 2017,” said Burchard.
